BREAKTHROUGH METHOD IN CARDIAC SURGERY! MORE ADVANTAGEOUS

Reading time is 4 mins

.
.
BREAKTHROUGH METHOD IN CARDIAC SURGERY! MORE ADVANTAGEOUS THAN OPEN OPERATION

A minimally invasive, that is, a surgical operation performed in the form of small incisions, which is a in cardiovascular surgery and is popularly known as a closed method, is becoming more preferred every day. Turkey Medicals member and hospital Cardiac and Vascular Surgeon Prof. Doctor stated that minimally invasive and robotic surgery provides important advantages for both doctors and patients, and said, “We have the opportunity to see more details than open surgery”.

Groundbreaking methods in the field of health care continue to give patients hope. During the pandemic, people are hesitant to go to hospitals. Cardiac and Vascular Surgeon Prof. Dr. made a call to citizens “Do not be afraid to come to the hospital”. Stating that all health workers have two doses of Biontech vaccine and hospitals have taken all precautions against coronavirus, said, “When two doses of Biontech vaccine are made, it definitely prevents transmission and disease. That’s why patients can easily get to and from the hospital. Hospitals are perhaps one of the safest places right now,” he said.

.
THE VACCINE PROTECTS THE HEART FROM THE VIRUS

Noting that the effect of vaccines and the virus on the heart has been discussed in the public for many months, said, “People have been distancing themselves from the vaccine because it causes inflammation in the heart muscle. There is research conducted, research of the American Institute for Disease Protection and Treatment. although the incidence has increased in young people aged 20-30 years, they are one in 100 thousand, and even the European Medicines Agency has announced in a million. When we look at it, it is much, much more that the coronavirus itself leads to inflammation of the heart muscle. For this reason, it is possible to have bigger heart

Vaccines are extremely safe in this regard. There is no such a risky situation as to be so afraid of inflammation of the heart muscle and not get vaccinated. He was vaccinated, a month later he had a heart attack. It’s more of a overlap situation. Coronary artery disease, atherosclerotic heart disease account for 40 percent of deaths. The formation of plaques in the coronary vessels does not occur for one reason or another. It happens a combination of many factors. The biggest reason is that there is a race, a genetic predisposition. Passing it from mother and father to that person with chromosomes. Many factors, such as diabetes, hypertension, sedentary lifestyle, high cholesterol, smoking, can cause this disease. Although some of these plaques form stenosis, they do not affect the current much, but it has been seen that these plaques are more torn in the corona,” he said.

.
MINIMALLY INVASIVE METHOD OF BYPASS

Emphasizing that technological developments have developed groundbreaking applications in the field of medicine, Prof. Dr. “Now we can do heart surgeries with a small incision. Technological developments are also reflected in medicine, whether we like it or not. I have been working in cardiac surgery in Turkey for about 30 years. I have also worked abroad and am observing developments in this field. Interest in the minimally invasive field has increased. Especially recently, both our country and Europe have gone too far in this regard. In particular, robotic surgery is currently the largest number of surgeries performed with the Da Vinci robot system in Turkey. We perform minimally invasive surgeries not only with a robot, but also videoterocopically,” he said.

Stating that the minimally invasive method and robotic surgery have a lot of advantages, said, “If you need to open it a little, we can enter it with a small incision from the left and remove the chest vein with a robot and bypass it. We also do mitral valve repair, replacement, heart tumor removal, rhythm disturbance surgeries and heart hole closure surgeries minimally invasively by entering with a small incision on the right side and videoterocopically. Then we make the change of the aortic valve with a 5 cm incision again from the middle line. As it can be seen, we are able to perform a large number of operations on a wide range with a small incision. Thanks to technological developments, this area has become even safer. The results are also very successful. We, as a team, first started these works in 1998. in 2002, we started the first valve replacement and valve repair operations. in 2004, we started coronary bypass surgery in Turkey and mitral valve repair operations with robotic surgery. We’re still moving on. There is also a lot of demand from patients. There is now a consciousness in the public opinion,” he said.

.
OUR PATIENTS ARE TRUSTING, SHOWING INTEREST

Prof. Dr. stated that patients do not perform the operation when they see too much risk in their condition, “In order for minimally invasive to be put into clinical use, it should give the same result as open, and the risk should be as much as it is. if it’s too much of a risk and it’s endangering the patient’s condition, we’re not doing it anyway. The risk is almost the same in robotic surgery and videoteroscopic minimally invasive as it is the risk in open surgeries. It doesn’t make much difference. But we see the heart valve better, for example. Because when we sit down on the head of the robot, it magnifies 10 times more. When you move the camera forward, you can see the structures inside the heart there. Of course, this gives an advantage. It’s a long time to learn a little,” he said.

In addition warned citizens about early detection,“Coronary artery disease is an insidious disease. He may appear before you without any symptoms. Early detection is very important. Therefore, do not disrupt your checks, check-ups. There was a fear with the pandemic, then there was a relief when the vaccine came out, but still the Cardiac patients don’t want to come to the Turkish hospital,” he added.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me